Investors

Date	Name	Title	Type	Shares Traded	Price Range
Jun 3, 2010	kolinski stuart	Officer	Option Execute	12,500	8.50
Mar 9, 2011	mccorkle douglas s	Officer	Option Execute	9,400	20.32
Mar 21, 2011	mccorkle douglas s	Officer	Option Execute	10,600	20.32
Feb 2, 2010	mccorkle douglas s	Officer	Option Execute	5,875	9.49 - 11.64
Dec 21, 2009	mccorkle douglas s	Officer	Option Execute	2,456	8.50
Oct 1, 2008	mccorkle douglas s	Officer	Option Execute	4,957	8.50 - 11.64
Oct 1, 2008	mccorkle douglas s	Officer	Option Execute	6,341	8.50 - 13.00
Oct 1, 2008	mccorkle douglas s	Officer	Option Execute	5,034	8.50 - 13.00
Nov 2, 2007	mccorkle douglas s	Officer	Option Execute	6,209	8.50 - 9.49
Feb 14, 2012	mccorkle douglas s	Officer	Option Execute	35,000	16.80 - 21.92
Dec 18, 2012	mccorkle douglas s	Officer	Option Execute	4,625	21.25
Dec 17, 2012	mccorkle douglas s	Officer	Option Execute	5,000	16.80
Aug 23, 2012	mccorkle douglas s	Officer	Option Execute	15,125	21.25 - 30.63
Apr 11, 2013	mccorkle douglas s	Officer	Option Execute	5,875	30.63
May 1, 2013	mccorkle douglas s	Officer	Option Execute	5,875	52.03
Jul 25, 2012	powchik peter	Officer	Option Execute	15,000	16.80
Aug 1, 2012	powchik peter	Officer	Option Execute	14,990	15.64 - 21.92
Sep 18, 2012	powchik peter	Officer	Option Execute	15,000	16.80
Dec 18, 2012	powchik peter	Officer	Option Execute	38,248	21.25 - 52.03
Jan 2, 2013	powchik peter	Officer	Option Execute	30,000	21.25
Showing 161-180 of 638 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.